companies innovating in obesity treatment glp-1 drugs 2025 How Employers Can Manage Costs Their Health Plans GLP-1 Pipeline Update: August 2025

W.SampathT

C.PaulS.Del TedescoE.Rinaudo-GaujousM.BoukhadraN.GeninC.et al (2014)

4.Enzyme marker inactivation or substrate failureMix the enzyme conjugate and substrate and check and judge by rapid color development Problem description: Low readingsPossible causes and corresponding countermeasures: 1.The microplate reader is not set up correctlyCheck wavelength and filter settings on the microplate reader/Turn on the ELISA reader in advance to preheat Problem description: Large coefficient of variationPossible causes and corresponding countermeasures: 1.Incorrect addition of liquidCheck the filling status Problem description: High background valuePossible causes and corresponding countermeasures: 1.The working concentration of the detection antibody is too highUse the recommended dilution factor 2.Incomplete washing of ELISA plateEnsure that each step is cleaned completely

H&E, Hematoxylin and eosin

Incubate 10-20 minutes at 37C